SPDR S&P Biotech ETF (NYSEARCA:XBI) Stake Cut by MinichMacGregor Wealth Management LLC

MinichMacGregor Wealth Management LLC decreased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 0.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 31,075 shares of the exchange traded fund’s stock after selling 119 shares during the period. MinichMacGregor Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $3,070,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of XBI. ORG Partners LLC bought a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at about $40,000. Quintet Private Bank Europe S.A. acquired a new position in SPDR S&P Biotech ETF in the third quarter valued at approximately $40,000. ORG Wealth Partners LLC bought a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at approximately $44,000. Waldron Private Wealth LLC bought a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at approximately $54,000. Finally, Resources Management Corp CT ADV raised its position in shares of SPDR S&P Biotech ETF by 30.3% during the 2nd quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock worth $55,000 after purchasing an additional 138 shares during the period.

SPDR S&P Biotech ETF Price Performance

NYSEARCA:XBI traded down $0.95 during midday trading on Tuesday, reaching $98.27. 1,393,600 shares of the company traded hands, compared to its average volume of 9,284,848. The firm has a market capitalization of $7.49 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The company has a fifty day moving average price of $98.88 and a 200 day moving average price of $95.04. SPDR S&P Biotech ETF has a twelve month low of $64.99 and a twelve month high of $103.52.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.